Mitra Behroozaghdam

518 total citations
12 papers, 355 citations indexed

About

Mitra Behroozaghdam is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Mitra Behroozaghdam has authored 12 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 2 papers in Pharmacology. Recurrent topics in Mitra Behroozaghdam's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (4 papers). Mitra Behroozaghdam is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (4 papers). Mitra Behroozaghdam collaborates with scholars based in Iran, Canada and United States. Mitra Behroozaghdam's co-authors include Mehrdad Hashemi, Maliheh Entezari, Afshin Taheriazam, Shokooh Salimimoghadam, Sepideh Mirzaei, Saeed Samarghandian, Mohsen Rashidi, Elahe Sadat Hejazi, Shamin Rezaei and Amirabbas Kakavand and has published in prestigious journals such as Cellular and Molecular Life Sciences, European Journal of Pharmacology and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Mitra Behroozaghdam

11 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitra Behroozaghdam Iran 9 248 185 41 27 24 12 355
Eman K. Habib Egypt 11 192 0.8× 115 0.6× 46 1.1× 25 0.9× 21 0.9× 24 371
Jiabin Dai China 8 217 0.9× 135 0.7× 39 1.0× 17 0.6× 15 0.6× 8 290
Junjie Gao China 10 220 0.9× 105 0.6× 44 1.1× 13 0.5× 22 0.9× 17 387
Dilek Cevik Türkiye 6 258 1.0× 90 0.5× 36 0.9× 33 1.2× 19 0.8× 6 358
Yaping Huang China 14 408 1.6× 297 1.6× 44 1.1× 33 1.2× 20 0.8× 28 532
Wen Qin-sheng China 9 258 1.0× 95 0.5× 59 1.4× 25 0.9× 20 0.8× 17 401
Genhai Shen China 10 202 0.8× 84 0.5× 60 1.5× 22 0.8× 36 1.5× 15 334
Zhenyu Zhou China 10 190 0.8× 99 0.5× 23 0.6× 29 1.1× 34 1.4× 14 333
Wanjun Yan China 10 334 1.3× 148 0.8× 50 1.2× 35 1.3× 31 1.3× 14 503

Countries citing papers authored by Mitra Behroozaghdam

Since Specialization
Citations

This map shows the geographic impact of Mitra Behroozaghdam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitra Behroozaghdam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitra Behroozaghdam more than expected).

Fields of papers citing papers by Mitra Behroozaghdam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitra Behroozaghdam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitra Behroozaghdam. The network helps show where Mitra Behroozaghdam may publish in the future.

Co-authorship network of co-authors of Mitra Behroozaghdam

This figure shows the co-authorship network connecting the top 25 collaborators of Mitra Behroozaghdam. A scholar is included among the top collaborators of Mitra Behroozaghdam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitra Behroozaghdam. Mitra Behroozaghdam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hashemi, Mehrdad, Maryam Bagheri, Mitra Behroozaghdam, et al.. (2023). Versatile function of AMPK signaling in osteosarcoma: An old player with new emerging carcinogenic functions. Pathology - Research and Practice. 251. 154849–154849. 3 indexed citations
2.
Hashemi, Mehrdad, Parham Rahmanian, Maliheh Entezari, et al.. (2023). Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance. Cellular & Molecular Biology Letters. 28(1). 33–33. 28 indexed citations
3.
Hashemi, Mehrdad, Rasoul Raesi, Zeinab Khazaei Koohpar, et al.. (2023). Biological and therapeutic viewpoints towards role of miR-218 in human cancers: Revisiting molecular interactions and future clinical translations. Cellular Signalling. 109. 110786–110786.
4.
Hashemi, Mehrdad, Mohammad Arad Zandieh, Zeinab Khazaei Koohpar, et al.. (2023). Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166714–166714. 35 indexed citations
5.
Taheriazam, Afshin, Mohammad Arad Zandieh, Mitra Behroozaghdam, et al.. (2023). Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control. European Journal of Pharmacology. 951. 175781–175781. 10 indexed citations
6.
Behroozaghdam, Mitra, Amirhossein Zabolian, Mehrdad Hashemi, et al.. (2022). Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action. Cellular and Molecular Life Sciences. 79(11). 539–539. 40 indexed citations
7.
Mirzaei, Sepideh, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.. (2022). siRNA and targeted delivery systems in breast cancer therapy. Clinical & Translational Oncology. 25(5). 1167–1188. 12 indexed citations
8.
Hashemi, Mehrdad, Mitra Behroozaghdam, Maliheh Entezari, et al.. (2022). Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacological Research. 184. 106418–106418. 115 indexed citations
9.
Entezari, Maliheh, Afshin Taheriazam, Sima Orouei, et al.. (2022). LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions. Biomedicine & Pharmacotherapy. 154. 113609–113609. 61 indexed citations
10.
Karimi, Aliasghar, et al.. (2017). Cytotoxic and Apoptogenic Effects of Cyanidin-3-Glucoside on the Glioblastoma Cell Line. World Neurosurgery. 108. 94–100. 34 indexed citations
11.
Behroozaghdam, Mitra, et al.. (2015). The effect of MDMA and pentoxifylline drug on bad/bcl-xl gene dosage expression changes on rat liver. Journal of paramedical sciences.. 6(3). 97–103. 1 indexed citations
12.
Behroozaghdam, Mitra, Mehrdad Hashemi, Gholamreza Javadi, Reza Mahdian, & Mansoureh Soleimani. (2015). Expression of bax and bcl2 Genes in MDMA-induced Hepatotoxicity on Rat Liver Using Quantitative Real-Time PCR Method through Triggering Programmed Cell Death. Iranian Red Crescent Medical Journal. 17(11). e24609–e24609. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eman K. Habib Breakdown of academic impact, for papers by Jiabin Dai Breakdown of academic impact, for papers by Junjie Gao Breakdown of academic impact, for papers by Dilek Cevik Breakdown of academic impact, for papers by Yaping Huang Breakdown of academic impact, for papers by Wen Qin-sheng Breakdown of academic impact, for papers by Genhai Shen Breakdown of academic impact, for papers by Zhenyu Zhou Breakdown of academic impact, for papers by Wanjun Yan
Rankless by CCL
2026